ici 118551 and interleukin-8

ici 118551 has been researched along with interleukin-8 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Knox, AJ; Pang, L	1
Abraham, G; Mittag, A; Nieber, K; Oehme, S; Schrödl, W; Tarnok, A	1

Other Studies

2 other study(ies) available for ici 118551 and interleukin-8

Article	Year
Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. American journal of respiratory cell and molecular biology, 2000, Volume: 23, Issue:1 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Androstadienes; Asthma; Cell Survival; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Drug Synergism; Fluticasone; Humans; Interleukin-8; Muscle, Smooth; Phosphodiesterase Inhibitors; Propanolamines; Receptors, Adrenergic, beta-2; Respiratory System; Rolipram; Salmeterol Xinafoate; Trachea; Tumor Necrosis Factor-alpha	2000
Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells. Pulmonary pharmacology & therapeutics, 2015, Volume: 30 Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Bronchi; Cells, Cultured; Cyclic AMP; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Isoproterenol; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors	2015

Article

Year

Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells.

American journal of respiratory cell and molecular biology, 2000, Volume: 23, Issue:1

Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Androstadienes; Asthma; Cell Survival; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Drug Synergism; Fluticasone; Humans; Interleukin-8; Muscle, Smooth; Phosphodiesterase Inhibitors; Propanolamines; Receptors, Adrenergic, beta-2; Respiratory System; Rolipram; Salmeterol Xinafoate; Trachea; Tumor Necrosis Factor-alpha

2000

Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.

Pulmonary pharmacology & therapeutics, 2015, Volume: 30

Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Bronchi; Cells, Cultured; Cyclic AMP; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Isoproterenol; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors

2015